Simple Summary Liver malignancy affects thousands of people, and its treatment is
constantly evolving. Ablative therapies are a series of minimally invasive modalities that treat …

The liver is a common site for both primary and secondary malignancy. Hepatic resection
and transplantation are the two treatment modalities that have been shown to achieve …

Surgical resection is often the first-line treatment option for primary and select metastatic
hepatic malignancies. A minority of patients with hepatocellular carcinoma undergo …

With increased use of medical imaging, the incidental detection of benign solid liver tumors
has become more frequent. Facing with benign disease, the indications for surgery are still …

Focal ablative techniques are promising tools in the treatment of unresectable primary and
secondary liver tumors. Despite a lack of randomized controlled trials, early data suggest …

Surgical resection has historically been considered the gold standard for curative treatment
in patients diagnosed with hepatocellular carcinoma (HCC), cholangiocarcinoma, colorectal …

The optimal management of hepatocellular carcinoma (HCC) is resection, but this is feasible
in only a minority of patients for a variety of reasons, including metastatic disease, major …

Locally Ablative Therapies of Hepatocellular Carcinoma Delayed diagnosis of
hepatocellular carcinomas (HCC) leads to a poor prognosis with a median survival time of …

Hepatocellular carcinoma (HCC) is a major cause of cancer-related death worldwide. This
disease can be treated through several surgical and nonsurgical approaches. Although the …

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide,
responsible for an estimated one million deaths annually. The incidence in the United States …